Home

etage Analytiker hoste ddp4 hæmmer komponent elevation ø

GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes - ScienceDirect
GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes - ScienceDirect

Frontiers | Clinical Use of DPP-4 Inhibitors
Frontiers | Clinical Use of DPP-4 Inhibitors

Glucagon.com
Glucagon.com

Dipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina through VE-cadherin Phosphorylation | Scientific Reports
Dipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina through VE-cadherin Phosphorylation | Scientific Reports

Linagliptin, A Xanthine-Based Dipeptidyl Peptidase-4 Inhibitor, Ameliorates Experimental Autoimmune Myocarditis | JACC: Basic to Translational Science
Linagliptin, A Xanthine-Based Dipeptidyl Peptidase-4 Inhibitor, Ameliorates Experimental Autoimmune Myocarditis | JACC: Basic to Translational Science

DPP4 degrade the GLP1 and incretion, which leads to suppression of the... | Download Scientific Diagram
DPP4 degrade the GLP1 and incretion, which leads to suppression of the... | Download Scientific Diagram

DPP4/CD32b/NF-κB Circuit: A Novel Druggable Target for Inhibiting CRP-Driven Diabetic Nephropathy - ScienceDirect
DPP4/CD32b/NF-κB Circuit: A Novel Druggable Target for Inhibiting CRP-Driven Diabetic Nephropathy - ScienceDirect

PDF] The effects of DPP-4 inhibitors on vascular endothelial function in diabetes | Semantic Scholar
PDF] The effects of DPP-4 inhibitors on vascular endothelial function in diabetes | Semantic Scholar

Worsening Heart Failure During the Use of DPP-4 Inhibitors: Pathophysiological Mechanisms, Clinical Risks, and Potential Influence of Concomitant Antidiabetic Medications | JACC: Heart Failure
Worsening Heart Failure During the Use of DPP-4 Inhibitors: Pathophysiological Mechanisms, Clinical Risks, and Potential Influence of Concomitant Antidiabetic Medications | JACC: Heart Failure

IJERPH | Free Full-Text | The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect
IJERPH | Free Full-Text | The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect

Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes | Scientific Reports
Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes | Scientific Reports

Molecules | Free Full-Text | Role of Dipeptidyl Peptidase 4 Inhibitors in Antidiabetic Treatment
Molecules | Free Full-Text | Role of Dipeptidyl Peptidase 4 Inhibitors in Antidiabetic Treatment

Antioxidants | Free Full-Text | Renoprotective Effects of DPP-4 Inhibitors
Antioxidants | Free Full-Text | Renoprotective Effects of DPP-4 Inhibitors

DPP-4 INHIBITORS - Dipeptidyl peptidase-4 inhibitor - Gliptins - GlobalRPH
DPP-4 INHIBITORS - Dipeptidyl peptidase-4 inhibitor - Gliptins - GlobalRPH

Illustration of potential synergistic effects of SGLT2 inhibitor with... | Download Scientific Diagram
Illustration of potential synergistic effects of SGLT2 inhibitor with... | Download Scientific Diagram

Frontiers | Emerging Role of Dipeptidyl Peptidase-4 in Autoimmune Disease
Frontiers | Emerging Role of Dipeptidyl Peptidase-4 in Autoimmune Disease

Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance | Nature
Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance | Nature

DPP4 Promotes Human Endothelial Cell Senescence and Dysfunction via the PAR2–COX-2–TP Axis and NLRP3 Inflammasome Activation | Hypertension
DPP4 Promotes Human Endothelial Cell Senescence and Dysfunction via the PAR2–COX-2–TP Axis and NLRP3 Inflammasome Activation | Hypertension

Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism - Natasha A Trzaskalski, Evgenia Fadzeyeva, Erin E Mulvihill, 2020
Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism - Natasha A Trzaskalski, Evgenia Fadzeyeva, Erin E Mulvihill, 2020

Role of DPP-4 Inhibitors in Clinical Practice
Role of DPP-4 Inhibitors in Clinical Practice

Clinical Use of DPP-4 Inhibitors | Semantic Scholar
Clinical Use of DPP-4 Inhibitors | Semantic Scholar

PDB-101: Global Health: Diabetes Mellitus: Drugs: DPP4 inhibitor: DPP4
PDB-101: Global Health: Diabetes Mellitus: Drugs: DPP4 inhibitor: DPP4

DPP-4 Inhibitors
DPP-4 Inhibitors

Pharmaceuticals | Free Full-Text | Dipeptidyl Peptidase (DPP)-IV Inhibitors with Antioxidant Potential Isolated from Natural Sources: A Novel Approach for the Management of Diabetes
Pharmaceuticals | Free Full-Text | Dipeptidyl Peptidase (DPP)-IV Inhibitors with Antioxidant Potential Isolated from Natural Sources: A Novel Approach for the Management of Diabetes

Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study - The Lancet Digital Health
Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study - The Lancet Digital Health

DPP (Dipeptidyl Peptidase)-4 Inhibitor Attenuates Ang II (Angiotensin II)–Induced Cardiac Hypertrophy via GLP (Glucagon-Like Peptide)-1–Dependent Suppression of Nox (Nicotinamide Adenine Dinucleotide Phosphate Oxidase) 4-HDAC (Histone Deacetylase) 4 ...
DPP (Dipeptidyl Peptidase)-4 Inhibitor Attenuates Ang II (Angiotensin II)–Induced Cardiac Hypertrophy via GLP (Glucagon-Like Peptide)-1–Dependent Suppression of Nox (Nicotinamide Adenine Dinucleotide Phosphate Oxidase) 4-HDAC (Histone Deacetylase) 4 ...